Contact the Editorial Team

Editorial correspondence

Iron Peptide Innovations welcomes correspondence on the research record: a citation quoted inaccurately, a regulatory reference gone out of date, or a peer-reviewed study on BPC-157 or TB-500 that belongs on the references page. Corrections that sharpen accuracy are the most useful messages that arrive here, and they are read carefully.

The most actionable notes name three things: the page in question, the exact passage, and the supporting citation — a DOI or PubMed ID wherever possible. That lets any proposed change be checked against the source quickly.

Editorial mailbox: editors@ironpeptideinnovations.com

What this digest cannot do

Iron Peptide Innovations is a map of the literature, not a clinic or a vendor, so it cannot:

• Advise on, recommend, or comment on human use of any peptide discussed here.
• Suggest a dose, schedule, or route of administration for any individual.
• Diagnose a condition or judge whether a particular research finding applies to a particular person.
• Sell, source, recommend, or help locate any compound from any supplier.
• Answer requests from athletes subject to anti-doping rules about using these compounds, given that both are WADA-prohibited.

Readers seeking medical guidance should consult a licensed clinician in their own jurisdiction. Replies to editorial correspondence are not guaranteed and may be delayed; the mailbox is monitored intermittently.